Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Derya Ipekcioglu, Menekse Sıla Yazar, Ozge Canbek, Ozge Yuksel, Kumru Senyasar Meterelliyoz & Mehmet Cem Ilnem. (2018) Electroconvulsive therapy combined with antipsychotic therapy in the treatment of acute schizophrenia inpatients: symptom profile of the clinical response. Psychiatry and Clinical Psychopharmacology 28:4, pages 363-370.
Read now
Read now
Richard D. Weiner & Irving M. Reti. (2017) Key updates in the clinical application of electroconvulsive therapy. International Review of Psychiatry 29:2, pages 54-62.
Read now
Read now
Shyam Sundar Arumugham, Jagadisha Thirthalli & Chittaranjan Andrade. (2016) Efficacy and safety of combining clozapine with electrical or magnetic brain stimulation in treatment-refractory schizophrenia. Expert Review of Clinical Pharmacology 9:9, pages 1245-1252.
Read now
Read now
Chaohua Huang, Yukun Kang, Bo Zhang, Bin Li, Changjian Qiu, Shanming Liu, Hongyan Ren, Yanchun Yang, Xiehe Liu, Tao Li & Wanjun Guo. (2015) Anti-N-methyl-d-aspartate receptor encephalitis in a patient with a 7-year history of being diagnosed as schizophrenia: complexities in diagnosis and treatment. Neuropsychiatric Disease and Treatment 11, pages 1437-1442.
Read now
Read now
Iulian Iancu, Nimrod Pick, Orit Seener-Lorsh & Pinhas Dannon. (2015) Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions: characteristics, indications, and results. Neuropsychiatric Disease and Treatment 11, pages 853-862.
Read now
Read now
Chiyo Shibasaki, Minoru Takebayashi, Yasutaka Fujita & Shigeto Yamawaki. (2015) Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study. Neuropsychiatric Disease and Treatment 11, pages 67-73.
Read now
Read now
Articles from other publishers (51)
Jan Exner, Gunnar Deuring, Erich Seifritz & Annette Beatrix Brühl. (2023) Dynamic impedance is correlated with static impedance and seizure quality parameters in bifrontal electroconvulsive therapy. Acta Neuropsychiatrica, pages 1-9.
Crossref
Crossref
Jagriti Yadav, Akansha Bhardwaj, Purushottam Jangid, Priti Singh & Rajiv Gupta. (2023) A Case Series of Noncatatonic Mutism with Poor Response to Conventional Treatment Approach. Annals of Indian Psychiatry 7:4, pages 371-374.
Crossref
Crossref
Stanley N. Caroff, Gabor S. Ungvari & Gábor Gazdag. (2022) Treatment of schizophrenia with catatonic symptoms: A narrative review. Schizophrenia Research.
Crossref
Crossref
Julia M. Lappin, Kimberley Davies, Maryanne O'Donnell & Ishan C. Walpola. (2022) Underuse of recommended treatments among people living with treatment-resistant psychosis. Frontiers in Psychiatry 13.
Crossref
Crossref
Kotaro Sugita, Yasuhiro Mori, Kousuke Kanemoto & Sotaro Sugita. (2022) Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy. Science Progress 105:3, pages 003685042211170.
Crossref
Crossref
Shyam Sundar Arumugham, Samir K. Praharaj, Umesh Shreekantiah, Vanteemar S. Sreeraj, Chandramouli Roy, Sonia Shenoy, Abhiram Narasimhan Purohith, Uppinkudru Chithra, Kiran Basawaraj Bagali, Sudhir Venkataramaiah, Gopala Krishna Kadarapura Nanjundaiah, Kandavel Thennarasu, Channaveerachari Naveen Kumar, Nishant Goyal, Basudeb Das, Urvakhsh Meherwan Mehta, Kesavan Muralidharan, Ganesan Venkatasubramanian, Preeti Sinha & Jagadisha Thirthalli. (2022) Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study. Wellcome Open Research 7, pages 212.
Crossref
Crossref
Shyam Sundar Arumugham, Samir K. Praharaj, Umesh Shreekantiah, Vanteemar S. Sreeraj, Chandramouli Roy, Sonia Shenoy, Abhiram Narasimhan Purohith, Uppinkudru Chithra, Kiran Basawaraj Bagali, Sudhir Venkataramaiah, Gopala Krishna Kadarapura Nanjundaiah, Kandavel Thennarasu, Channaveerachari Naveen Kumar, Nishant Goyal, Basudeb Das, Urvakhsh Meherwan Mehta, Kesavan Muralidharan, Ganesan Venkatasubramanian, Preeti Sinha & Jagadisha Thirthalli. (2022) Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study. Wellcome Open Research 7, pages 212.
Crossref
Crossref
Young Tak Jo, Jungsun Lee & Yeon Ho Joo. (2022) Fever as a Side Effect after Electroconvulsive Therapy. Neuropsychobiology 81:1, pages 19-27.
Crossref
Crossref
Gonzague Corbin de Mangoux, Ali Amad, Clélia Quilès, Franck Schürhoff & Baptiste Pignon. (2022) History of ECT in Schizophrenia: From Discovery to Current Use. Schizophrenia Bulletin Open 3:1.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
1
224
.
Carmen Black ParkerWilliam V. McCallE. Vanessa Spearman-McCarthyPeter RosenquistNiayesh Cortese. (2021) Clinicians’ Racial Bias Contributing to Disparities in Electroconvulsive Therapy for Patients From Racial-Ethnic Minority Groups. Psychiatric Services 72:6, pages 684-690.
Crossref
Crossref
Harold A. Sackeim. (2021) Staging and Combining Brain Stimulation Interventions. The Journal of ECT 37:2, pages 80-83.
Crossref
Crossref
Soichiro Maruyama, Shuken Boku, Satoshi Okazaki, Hiroki Kikuyama, Yoshito Mizoguchi, Akira Monji, Ikuo Otsuka, Ichiro Sora, Tetsufumi Kanazawa, Akitoyo Hishimoto & Hiroshi Yoneda. (2020) ATP and repetitive electric stimulation increases leukemia inhibitory factor expression in astrocytes: A potential role for astrocytes in the action mechanism of electroconvulsive therapy. Psychiatry and Clinical Neurosciences 74:5, pages 311-317.
Crossref
Crossref
A. Umair Janjua, Amitha L. Dhingra, Robert Greenberg & William M. McDonald. (2020) The Efficacy and Safety of Concomitant Psychotropic Medication and Electroconvulsive Therapy (ECT). CNS Drugs 34:5, pages 509-520.
Crossref
Crossref
Anna Stippl, Fatma Nur Kirkgöze, Malek Bajbouj & Simone Grimm. (2020) Differential Effects of Electroconvulsive Therapy in the Treatment of Major Depressive Disorder. Neuropsychobiology 79:6, pages 408-416.
Crossref
Crossref
Erika Martínez-Amorós, Pilar Serra, Ximena Goldberg, Lara Urraca, Diego J. Palao, Mikel Urretavizcaya & Narcís Cardoner. (2020) Clinical outcome after discontinuation of maintenance electroconvulsive therapy. A retrospective follow-up study. Revista de Psiquiatría y Salud Mental (English Edition) 13:1, pages 5-10.
Crossref
Crossref
Erika Martínez-Amorós, Pilar Serra, Ximena Goldberg, Lara Urraca, Diego J. Palao, Mikel Urretavizcaya & Narcís Cardoner. (2020) Evolución clínica tras la discontinuación de la terapia electroconvulsiva de mantenimiento. Estudio de seguimiento retrospectivo. Revista de Psiquiatría y Salud Mental 13:1, pages 5-10.
Crossref
Crossref
David Yoshihito Kumagaya. (2019) Acute electroconvulsive therapy in the elderly with schizophrenia and schizoaffective disorder: A case series. Asia-Pacific Psychiatry 11:4.
Crossref
Crossref
Sandeep Grover, Swapnajeet Sahoo, Anjumoni Rabha & Raman Koirala. (2018) ECT in schizophrenia: a review of the evidence. Acta Neuropsychiatrica 31:03, pages 115-127.
Crossref
Crossref
Rachel Waford & Carina A. Iati. 2019. Pseudoscience in Child and Adolescent Psychotherapy. Pseudoscience in Child and Adolescent Psychotherapy
96
109
.
M. V. Ivanov & D. S. Zubov. (2019) Electroconvulsive therapy in treatment of resistant schizophrenia: biological markers of efficacy and safety. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:3, pages 92.
Crossref
Crossref
Nobuhisa Kanahara, Makihiko Hirabayashi, Takashi Mamada, Masahiko Nishimoto & Masaomi Iyo. (2018) Combination therapy of electroconvulsive therapy and aripiprazole for dopamine supersensitivity psychosis. Schizophrenia Research 202, pages 398-400.
Crossref
Crossref
Gabor S. Ungvari, Jozsef Gerevich, Rozália Takács & Gábor Gazdag. (2018) Schizophrenia with prominent catatonic features: A selective review. Schizophrenia Research 200, pages 77-84.
Crossref
Crossref
Lucie Kalisova, Katerina Madlova, Jakub Albrecht, Jiri Michalec, Marketa Kubinova & Jiri Raboch. (2018) Electroconvulsive Therapy in the Czech Republic. The Journal of ECT 34:2, pages 108-112.
Crossref
Crossref
Jan Engelmann, Stefanie Wagner & Sarah Kayser. (2018) Update Elektrokonvulsionstherapie — klinische Anwendung. InFo Neurologie & Psychiatrie 20:1, pages 40-48.
Crossref
Crossref
Qian Li, Yun-Ai Su, Yu-Tao Xiang, Liang Shu, Xin Yu, Gabor S. Ungvari, Stephen J. Seiner, Helen F.K. Chiu, Yu-Ping Ning, Gao-Hua Wang, Ke-Rang Zhang, Tao Li, Li-Zhong Sun, Jian-Guo Shi, Xian-Sheng Chen, Qi-Yi Mei, Ke-Qing Li & Tian-Mei Si. (2017) Electroconvulsive Therapy in Schizophrenia in China. The Journal of ECT 33:2, pages 138-142.
Crossref
Crossref
Philipp Arthur Thomann, Robert Christian Wolf, Henrike Maria Nolte, Dusan Hirjak, Stefan Hofer, Ulrich Seidl, Malte Sebastian Depping, Bram Stieltjes, Klaus Maier-Hein, Fabio Sambataro & Torsten Wüstenberg. (2017) Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression. Brain Stimulation 10:3, pages 637-644.
Crossref
Crossref
Sandeep Grover, Subho Chakrabarti, Nandita Hazari & Ajit Avasthi. (2017) Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study. Psychiatry Research 249, pages 349-353.
Crossref
Crossref
Alfonso González-Valderrama, Carmen Paz Castañeda, Cristián Mena, Juan Undurraga, Pilar Mondaca, Matías Yañez, Paula Bedregal & Ruben Nachar. (2017) Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort. Early Intervention in Psychiatry 11:1, pages 77-82.
Crossref
Crossref
Beatrice Frajo-Apor, Monika Edinger, Stefan Schmidinger, Wolfgang Fleischhacker & Alex Hofer. (2017) Successful Electroconvulsive Therapy in a Clozapine-Refractory Schizophrenia Patient with Meningioma. Clinical Schizophrenia & Related Psychoses 10:4, pages 225-226.
Crossref
Crossref
Armağan Özdemir, Cana Aksoy Poyraz, Evrim Erten, Emre Çırakoğlu & Nesrin Tomruk. (2016) Electroconvulsive Therapy in Women: A Retrospective Study from a Mental Health Hospital in Turkey. Psychiatric Quarterly 87:4, pages 769-779.
Crossref
Crossref
Sandarsh Surya, Peter B. Rosenquist & W. Vaughn McCall. 2015. Neuromodulation in Psychiatry. Neuromodulation in Psychiatry
429
453
.
Silvia Hoirisch-Clapauch & Antonio Nardi. (2015) Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator. International Journal of Molecular Sciences 16:11, pages 27550-27560.
Crossref
Crossref
Mehmet E. Dokucu. (2015) Neuromodulation Treatments for Schizophrenia. Current Treatment Options in Psychiatry 2:3, pages 339-348.
Crossref
Crossref
E M van Buel, K Patas, M Peters, F J Bosker, U L M Eisel & H C Klein. (2015) Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?. Translational Psychiatry 5:7, pages e609-e609.
Crossref
Crossref
Eunice Hagen, Dana Shprung, Elena Minakova, James WashingtonIIIIII, Udaya Kumar, Don Shin, Raman Sankar & Andrey Mazarati. (2015) Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy. Neurotherapeutics 12:3, pages 657-666.
Crossref
Crossref
Sandeep Grover, Nandita Hazari & Natasha Kate. (2015) Combined use of clozapine and ECT: a review. Acta Neuropsychiatrica 27:3, pages 131-142.
Crossref
Crossref
Masaki NishiguchiHiroki KikuyamaTetsufumi KanazawaAtsushi TsutsumiTakao KanekoHiroyuki UenishiYasuo KawabataSeiya KawashigeJun KohHiroshi Yoneda. (2015)
Increases in iPS Transcription Factor (
Oct4
,
Sox2
,
c-Myc
, and
Klf4
) Gene Expression after Modified Electroconvulsive Therapy
. Psychiatry Investigation 12:4, pages 532.
Crossref
Crossref
Francesca Regen & Franziska van Hall. (2014) Therapieresistente Schizophrenie. NeuroTransmitter 25:10, pages 38-42.
Crossref
Crossref
Markus Dold & Stefan Leucht. (2014) Pharmakotherapie der therapieresistenten Schizophrenie. PSYCH up2date 8:05, pages 281-297.
Crossref
Crossref
Daniel C. Javitt. (2014) Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia. Current Treatment Options in Psychiatry 1:2, pages 107-120.
Crossref
Crossref
Nancy Kerner & Joan Prudic. (2014) Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry 4:1, pages 33-54.
Crossref
Crossref
Peter B. Rosenquist, Anthony O. Ahmed & W. Vaughn McCall. 2014. Treatment–Refractory Schizophrenia. Treatment–Refractory Schizophrenia
107
120
.
Jeffrey T. Rado & Edgar I. Hernandez. 2014. Schizophrenia. Schizophrenia
139
160
.
Jeffrey T. Rado, Edgar I. Hernandez & Philip G. Janicak. (2013) Novel Approaches for Managing Schizophrenia. Psychopharm Review 48:11, pages 81-87.
Crossref
Crossref
Maurizio Pompili, David Lester, Giovanni Dominici, Lucia Longo, Giulia Marconi, Alberto Forte, Gianluca Serafini, Mario Amore & Paolo Girardi. (2013) Indications for electroconvulsive treatment in schizophrenia: A systematic review. Schizophrenia Research 146:1-3, pages 1-9.
Crossref
Crossref
H. Janouschek, T. Nickl-Jockschat, M. Haeck, B. Gillmann & M. Grözinger. (2013) Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders. Journal of Psychiatric Research 47:5, pages 686-693.
Crossref
Crossref
M. V. Seeman. (2012) Clinical interventions for women with schizophrenia: pregnancy. Acta Psychiatrica Scandinavica 127:1, pages 12-22.
Crossref
Crossref
Bettina Grager & Jan Di Pauli. 2013. Elektrokonvulsionstherapie kompakt. Elektrokonvulsionstherapie kompakt
73
80
.
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
31
88
.
Ahmed-Ramadan Sadek, Gillian E. Knight & Geoffrey Burnstock. (2011) Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling. Purinergic Signalling 7:4, pages 447-452.
Crossref
Crossref